Latrepirdine

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Latrepirdine is an orally active, and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.

Latrepirdine, also known as dimebolin (sold as Dimebon), is an antihistamine drug which has been used clinically in Russia since 1983. Research is continuing in both Russia and western nations into potential applications as a neuroprotective drug to combat Alzheimer's disease and, possibly, as a nootropic as well. However, a Phase III clinical trial for Alzheimer's disease treatment failed to show any benefit.

Latrepirdine dimebolin Dimebon

Others

Other Targets

GluR , Histamine receptor , 5-HT

Inflammation/Immunology

——

97657-92-6

392.37

C21H25N3·2HCl

98%

DMSO : 6.4 mg/mL. 16.31 mM;

CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl

2,8-dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride

(-20℃)

With Ice Pack

≥ 2 years